Rachel A. Nugent, Ph.D. is Vice President for Global Non-communicable Diseases at RTI International. Previously, Rachel was the DCPN Principal Investigator and Director for the DCP - WHO EMRO collaboration, as well as a DCP3 Series Editor and volume editor the following volumes: Cardio-metabolic and Respiratory Disease; Environmental Health and Injury Prevention; Major Infectious Diseases; and Disease Control Priorities.
She joined RTI in February 2016 to lead a global initiative to prevent and reduce the health and economic burdens of chronic non-communicable diseases in low- and middle-income countries. Prior to this position, Rachel was Associate Professor in the Department of Global Health at the University of Washington and Director of the Disease Control Priorities Network. She has advised the World Health Organization, the U.S. Government, and non-profit organizations on the economics and policy environment of NCDs. She is a member of WHO’s Expert Advisory Panel on Management of Non Communicable Diseases (NCDs), the Abraaj Health Care Fund Social Impact Committee, and The Lancet Commission on NCDIs of the Poorest Billion. She led a Lancet Task Force and Series on NCDs and Economics (2018). She served on the U.S. Institute of Medicine Committee on Economic Evaluation for Investments in Children, Youth, and Families (2015-2016), was co-chair of the IOM Workshop on Country-Level Decision Making for Control of Chronic Diseases (2012), and a member of the IOM Committee on Promoting Cardiovascular Health in the Developing World (2008-2010).
Rachel focuses on using economic analysis for priority-setting in health, and has worked with global and national institutions to increase use of evidence for decision-making. Her recent work includes tracking donor funding on NCDs, and assessing costs and benefits of NCD policies and interventions. She received her M.Phil. and Ph.D. degrees in economics from the George Washington University in Washington, DC, USA.